Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Clark Nugent is active.

Publication


Featured researches published by Clark Nugent.


Journal of The American Society of Nephrology | 1993

Angiotensin-converting enzyme inhibitor fetopathy.

Peter G. Pryde; Aileen B. Sedman; Clark Nugent; Mason Barr

Angiotensin-converting enzyme (ACE) inhibitors are widely used for controlling hypertension. Their use in women who are pregnant is not without risk to the fetus. We describe three infants exposed in utero to ACE inhibitors who had adverse outcomes. These cases, combined with other reports in the literature, suggest strongly that these drugs are fetotoxic. ACE inhibitor fetopathy is characterized by fetal hypotension, anuria-oligohydramnios, growth restriction, pulmonary hypoplasia, renal tubular dysplasia, and hypocalvaria. Although the true frequency of adverse fetal effects has yet to be determined, because of the debilitating and lethal nature of the fetal damage when it occurs, it is our recommendation that ACE inhibitors not be used in pregnancy, particularly in the second and third trimesters.


Journal of Pediatric Surgery | 1999

Prenatal diagnosis of congenital cystic adenomatoid malformation and its postnatal presentation, surgical indications, and natural history

Kathleen van Leeuwen; Daniel H. Teitelbaum; Ronald B. Hirschl; Edward Austin; Susan H. Adelman; Theodore Z. Polley; Kelley W. Marshall; Arnold G. Coran; Clark Nugent

BACKGROUND/PURPOSE Regression of a cystic adenomatoid malformation (CAM) in a fetus is well described. Little, however, is known about the postnatal course of these infants. This study attempts to correlate the prenatal course of CAMs with postnatal symptoms, radiological manifestations, and need for surgery. METHODS The clinical course of patients with a CAM diagnosed prenatally were retrospectively reviewed. Inclusion in the study required a prenatal ultrasound scan documenting a CAM. RESULTS Over 10 years, 14 patients with a CAM were diagnosed prenatally. Six (43%) showed a partial in utero regression. Four patients were symptomatic at birth and underwent a resection as newborns. Ten patients were asymptomatic at birth, and eight of these had normal chest x-rays. Elective resection has been performed in 3 of these 10, and two additional children are scheduled to undergo an excision near 1 year of age. The remaining five patients have undergone follow-up nonoperatively for a mean of 36 +/- 15 months. Of the seven asymptomatic patients not undergoing immediate surgery, only one has shown a slight postnatal regression, despite five of these showing regression in utero. None have become symptomatic. CONCLUSIONS The results suggest that regression of a CAM on prenatal ultrasound scan is common, but this process does not continue after birth. A normal chest x-ray does not indicate complete regression of a CAM; a computed tomography (CT) scan is required to evaluate such patients, and will generally demonstrate a CAM. Asymptomatic patients with a CAM may be followed up nonoperatively with no apparent adverse effects. The decision and timing of an excision in an asymptomatic patient remains controversial among pediatric surgeons.


American Journal of Obstetrics and Gynecology | 2003

Specialized prenatal care and maternal and infant outcomes in twin pregnancy

Barbara Luke; Morton B. Brown; Ruta Misiunas; Elaine Anderson; Clark Nugent; Cosmas van de Ven; Barbara Burpee; Shirley Gogliotti

OBJECTIVE This study was undertaken to evaluate the effect of a prenatal nutrition and education program on twin pregnancy, neonatal, and early childhood outcomes. STUDY DESIGN This prospective intervention study of women who participated in a specialized program (Program Pregnancies) versus nonparticipants included twice-monthly visits, dietary prescription of 3000 to 4000 kcal per day, multimineral supplementation, and patient education. RESULTS Program Pregnancies were associated with improved pregnancy outcomes (preeclampsia, adjusted odds ratio [AOR] 0.41, 95% CI, 0.23-0.75; preterm premature rupture of membranes, AOR 0.35, 95% CI, 0.20-0.60; delivery <36 weeks, AOR 0.62, 95% CI, 0.43-0.89; low birth weight, AOR 0.42, 95% CI, 0.29-0.61), significantly longer gestations (+7.6 days), higher birth weights (+220 g), lower neonatal morbidity (retinopathy of prematurity, necrotizing enterocolitis, intraventricular hemorrhage, or ventilator support, AOR 0.44, 95% CI, 0.31-0.62), length of stay (-5.3 days), and cost per twin (-14,023 dollars). Through 3 years of age, program children were significantly less likely to be rehospitalized (AOR 0.31, 95% CI, 0.11-0.91) or to be developmentally delayed (AOR 0.65, 95% CI, 0.44-0.96). CONCLUSION Program participation was associated with improved outcomes at birth and through age 3 years.


American Journal of Obstetrics and Gynecology | 2003

Antenatal factors associated with significant birth weight discordancy in twin gestations.

Victor Hugo Gonzalez-Quintero; Barbara Luke; Mary Jo O'Sullivan; Ruta Misiunas; Elaine Anderson; Clark Nugent; Frank R. Witter; Jill Mauldin; Roger B. Newman; Mary E. D'Alton; David A. Grainger; George R. Saade; Gary D.V. Hankins; George Macones

OBJECTIVE The purpose of this study was to evaluate factors that are associated with significant birth weight discordancy. STUDY DESIGN As a part of an ongoing collaborative study of twins, maternal and fetal data were obtained from the medical records of twin gestations at eight medical centers. The study population was divided into groups by difference in birth weight discordancy (>or=20%, >or=25%, and >or=30%) RESULTS Severe birth weight discordancy was associated with fetal growth deceleration by 20 to 28 weeks (adjusted odds ratio, 4.90; 95% CI, 3.15-7.64) and between 28 weeks to birth (adjusted odds ratio, 3.48; 95% CI, 1.72-7.06). Antenatal bleeding (adjusted odds ratio, 1.86; 95% CI, 1.08-3.21), preeclampsia (adjusted odds ratio, 1.70, 95% CI, 1.21-2.41), and monochorionicity (adjusted odds ratio, 2.35, 95% CI, 11.71-3.23) were also associated with birth weight discordancy. CONCLUSION These data demonstrate the importance of the early diagnosis of placental chorionicity, because monochorionicity is associated with a 2-fold increase in birth weight discordancy in twin gestations.


American Journal of Obstetrics and Gynecology | 1991

Twin gestation: Influence of placentation on fetal growth

Gabriella Pridjian; Clark Nugent; Mason Barr

To study fetal growth in twin gestation, morphometric autopsy data of 52 midgestation twin pairs who were stillborn or who died less than or equal to 24 hours after birth were analyzed. Twins were divided into three groups: (1) monozygotic: diamniotic, monochorionic placenta (n = 18); (2) dizygotic: diamniotic, dichorionic placenta, unlike sex (n = 12); (3) like-sex: placenta diamniotic, dichorionic in 63.6%, unknown in 36.4% (n = 22). The monozygotic group had a significantly higher rate of growth discordance, which was defined as a greater than 20% difference in body weight (monozygotic 72.2%, dizygotic 16.7%, like-sex 0%), and polyhydramnios (monozygotic 50%, dizygotic 0%, like-sex 9.1%). Organ weight z scores for body weight and brain weight standards were calculated for the smaller and larger of each twin pair. In the monozygotic group highly significant z scores were obtained for brain weight in the smaller twin (z = 2.71, p = 0.003, body weight standards) and heart weight in the larger twin (body weight standards, z = 3.87, p less than 0.001; brain weight standards, z = 3.64, p less than 0.001). We conclude that monozygotic twins with diamniotic, monochorionic placentation have a high degree of brain-sparing growth restriction in the smaller twin and cardiac hyperplasia in the larger twin, most likely caused by hemodynamic inequalities.


Obstetrics and Gynecology Clinics of North America | 2008

Childbirth Education and Birth Plans

Joanne Motiño Bailey; Patricia Crane; Clark Nugent

Childbirth education is considered a key component to prenatal care, although many women do not receive any formalized preparation. There are multiple models of childbirth education for both within health care settings, including Centering Pregnancy, and external programs, such as Lamaze and Bradley. As a component of childbirth preparation, a birth plan can be a medium to improve patient-provider communication regarding a desired labor and birth experience and improve satisfaction with care.


Fetal Diagnosis and Therapy | 2009

Giant Pulmonary Sequestration: The Rare Case Requiring the EXIT Procedure with Resection and ECMO

George B. Mychaliska; Benjamin S. Bryner; Clark Nugent; John Barks; Ronald B. Hirschl; Kimberly McCrudden; Mark C. Chames; Carlen Gomez-Fifer; Monica N. Servin; S. Devi Chiravuri

Although most prenatally diagnosed pulmonary sequestrations (PS) are asymptomatic, large lesions are associated with pleural effusions and pulmonary hypoplasia. We present the first reported case of a prenatally diagnosed giant extralobar pulmonary sequestration that required the ex utero intrapartum treatment (EXIT) procedure with resection and extracorporeal membrane oxygenation (ECMO). We discuss the compelling rationale for performing EXIT-resection-ECMO in the setting of a large thoracic mass and anticipated severe respiratory failure at birth.


Vox Sanguinis | 1992

Appropriate Serological Testing in Pregnancy

W. John Judd; E. Ann Steiner; Clark Nugent

We read with interest the recent report by Garner et al. [l], in which anti-E was detected early in pregnancy solely through the use of enzymetreated red blood cells (RBC). The serological reactivity of this anti-E changed dramatically during pregnancy; the antibody became detectable by the indirect antiglobulin test, and at 37 weeks’ gestation had a titer of 512. Delivery at 40 weeks’ gestation yielded an infant affected with hemolytic disease of the newborn (HDN) requiring exchange transfusion and 4 days of phototherapy. This case was further complicated by antiK1, stimulated by prior transfusions, that was present throughout the pregnancy but did not contribute to the HDN, and an anti-c that was detected solely in tests with enzyme-treated RBCs at 35 weeks’ gestation, but was not demonstrable in the infant at delivery. While we concur with the authors that there is a need to screen both Rh D-positive and Rh D-negative women for RBC alloantibodies early in pregnancy, and while we agree that once an antibody has been detected it should be identified and evaluated for its potential to cause HDN, we Appropriate Serological Testing in Pregnancy


Twin Research and Human Genetics | 2005

The Hispanic paradox in twin pregnancies.

Barbara Luke; Morton B. Brown; Ruta Misiunas; Victor Hugo Gonzalez-Quintero; Clark Nugent; Cosmas van de Ven; Frank R. Witter; Roger B. Newman; Mary E. D'Alton; Gary D.V. Hankins; David A. Grainger; George Macones

The objective of this study was to compare length of gestation, fetal growth, and birthweight by race/ethnicity and pregravid weight groups in twin pregnancies. Three thousand and thirty-six twin pregnancies of 28 weeks or more gestation were divided by race/ethnicity (White, Black and Hispanic), and pregravid body mass index (BMI) groups (less than 25.0 vs. 25.0 or more). Outcomes were modeled using multiple regression, controlling for confounders, with White non-Hispanic women as the reference group. Hispanic women had the highest average birthweight and the longest gestation, as well as the lowest proportions of low birthweight, very low birthweight, preterm and early preterm births of the 3 race/ethnicity groups. In the multivariate analyses, Hispanic women had significantly longer gestations (by 7.8 days) and faster rates of fetal growth midgestation (20 to 28 weeks, by 17.4 g/week) and late gestation (after 28 weeks, by 5.3 g/week), whereas Black women had significantly slower rates of fetal growth (by 5.7 g/week and by 4.5 g/week, respectively). These findings in twins reflect the racial and ethnic disparities previously shown in singletons, including the Hispanic paradox of longer gestations and higher rates of fetal growth.


Twin Research and Human Genetics | 2005

Midupper arm circumference (MUAC) changes in late pregnancy predict fetal growth in twins

Mary L. Hediger; Barbara Luke; Cosmas van de Ven; Clark Nugent

The objective of the study was to test the hypothesis that changes in arm anthropometry can be used to determine the risk of faltering growth in twin gestations. Serial data on midupper arm circumference (MUAC) and maternal weight gain were collected from a sample of 156 mothers. Changes in MUAC were monitored from 20 to 34 weeks. Women with a large loss of MUAC (greater than 1.5 cm), particularly when it occurred within two to four weeks of delivery, were significantly heavier, had higher pregravid Body Mass Indexes (BMIs), but gained less weight than mothers with no change in MUAC. In analysis of covariance models adjusting for length of gestation, black ethnicity, males per twin pair, monochorionicity, and baseline MUAC at 20 weeks, a large loss of MUAC was associated with significantly lower birthweight (2263 g vs. 2499 g) and birthweight z-score (-0.92 SDU vs. -0.39 SDU). Changes in MUAC from 20 to 34 weeks, and especially near delivery, are significantly associated with fetal growth in twin pregnancies. A positive change may indicate that the mother has adequate dietary intake or nutrient stores to continue to accrue lean body mass and support fetal growth, while a loss of MUAC indicates that dietary intake or nutrient stores may be inadequate. This simple, relatively precise, measure of change in maternal body composition during pregnancy may be useful in identifying twin pregnancies at risk for faltering intrauterine growth, particularly among overweight or obese women.

Collaboration


Dive into the Clark Nugent's collaboration.

Top Co-Authors

Avatar

Barbara Luke

Michigan State University

View shared research outputs
Top Co-Authors

Avatar

Roger B. Newman

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mary L. Hediger

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jill Mauldin

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge